Correlating interleukin-12 stimulated interferon-γ production and the absence of ectodermal dysplasia and anhidrosis (EDA) in patients with mutations in NF-κB essential modulator (NEMO)

J Clin Immunol. 2014 May;34(4):436-43. doi: 10.1007/s10875-014-9998-2. Epub 2014 Feb 28.

Abstract

Objective: Patients with hypomorphic mutations in Nuclear Factor-κB Essential Modulator (NEMO) are immunodeficient (ID) and most display ectodermal dysplasia and anhidrosis (EDA). We compared cytokine production by NEMO-ID patients with and without EDA.

Methods: PBMCs of NEMO-ID patients, four with EDA carrying E315A, C417R, D311N and Q403X, and three without EDA carrying E315A, E311_L333del and R254G, were cultured with PHA, PHA plus IL-12p70, LPS, LPS plus IFN-γ, TNF and IL-1β. The production of various cytokines was measured in the supernatants. Fifty-nine healthy individuals served as controls.

Results: PBMCs of NEMO-ID patients without EDA produce subnormal amounts of IFN-γ after stimulation with PHA, but normal amounts of IFN-γ after PHA plus IL-12p70. In contrast, IFN-γ production by patients with EDA was low in both cases. Patients with EDA also generate lower PHA-stimulated IL-10 and IL-1β than controls, whereas the production of these cytokines by patients without EDA was normal.

Conclusion: Responses of PBMCs in NEMO-ID patients with EDA to PHA with and without IL-12p70 appear less robust than in NEMO-ID patients without EDA. This possibly indicates a better preserved NEMO function in our patients without EDA.

MeSH terms

  • Adult
  • Case-Control Studies
  • Ectodermal Dysplasia / complications
  • Ectodermal Dysplasia / genetics
  • Ectodermal Dysplasia / immunology*
  • Ectodermal Dysplasia / pathology
  • Female
  • Genetic Diseases, X-Linked / complications
  • Genetic Diseases, X-Linked / genetics
  • Genetic Diseases, X-Linked / immunology*
  • Genetic Diseases, X-Linked / pathology
  • Humans
  • I-kappa B Kinase / genetics
  • I-kappa B Kinase / immunology*
  • Immunologic Deficiency Syndromes / complications
  • Immunologic Deficiency Syndromes / genetics
  • Immunologic Deficiency Syndromes / immunology*
  • Immunologic Deficiency Syndromes / pathology
  • Interferon-gamma / biosynthesis*
  • Interleukin-10 / biosynthesis
  • Interleukin-12 / pharmacology*
  • Interleukin-1beta / biosynthesis
  • Leukocytes, Mononuclear / drug effects*
  • Leukocytes, Mononuclear / immunology
  • Leukocytes, Mononuclear / pathology
  • Lipopolysaccharides / pharmacology
  • Male
  • Middle Aged
  • Phytohemagglutinins / pharmacology
  • Primary Cell Culture
  • Primary Immunodeficiency Diseases
  • Signal Transduction
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • IKBKG protein, human
  • IL10 protein, human
  • Interleukin-1beta
  • Lipopolysaccharides
  • Phytohemagglutinins
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Interleukin-12
  • Interferon-gamma
  • I-kappa B Kinase

Supplementary concepts

  • NEMO mutation with immunodeficiency